In addition, adaptive changes in the ECS have been observed in intestinal biopsies from colon cancer patients, such as increased endocannabinoid levels, down-regulation of CB1 and up-regulation of CB2 receptor expression [9– 11]. Here, CNR1 is linked to colonic neoplasm.